Comments for OSIP - Stockpickr! Your Source for Stock Ideas

Comments for OSIP

Added By	Comments	Type	Date Added
barrons3	At 32, OSI Pharmaceuticals trades for 18 times next year's earnings. The stock could rally to 45 in the coming year as sales of OSI's key drug, Tarceva, continues to climb.	Love	July 25, 2009
barrons3	Huckman said some of the companies to watch are OSI Pharma(OSIP) which is expected to release test results on a cancer drug this weekend, and Medivation(MDVN), which is due to come out with some prostate cancer drug results.	Love	June 03, 2009
barrons3	That could move a slew of players including OSI Pharmaceuticals (OSIP), Cougar Biotech (CGRB) , Medarex (MEDX), Exelixis (EXEL), and Allos (ALTH).	Love	May 13, 2009
barrons3	Takeover targets are wide ranging and include Biogen [BIIB], Amylin (AMLN), OSI Pharma [OSIP], and Vertex Pharma [VRTX], says Huckman.	Love	January 07, 2009
Trading Nymph	3:30	Love	December 30, 2008
High Dividends	6.4	Love	November 19, 2008
Tachyon	Tecbnical	Love	October 13, 2007
elyodj	BI, checkout this BioTech	Love	August 24, 2007
kisu	This is a cancer and diabetic play. Very likely takeover candidate. Stock has great upside potential	Love	February 27, 2007
bbaker58	PHAR	Love	February 11, 2007
Larry Roberts	Out of Favor because of pruchase of EYET (drug Mancugen). Other pipeline strong	Love	January 23, 2007
Scott C Ausburn	drugs	Love	January 13, 2007